EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Prognostic Impact of Nectin4 and IRF6 Expression in Patients Undergoing Radical Cystectomy for Muscle-Invasive Bladder Cancer

DOMINIK ENDERLIN, MARIA GLOOR, UWE BIERI, ALEKHYA MAZUMDAR, SOUZAN SALEMI, NIELS RUPP, HOLGER MOCH, DANIEL EBERLI, CÉDRIC POYET

Cancer Diagnosis & Prognosis · 2026-11-01 · 6 (6) · 947-960

DOI: 10.21873/cdp.10597 ↗
AbstractBibliografische Angaben

Abstract

Background/Aim: Reliable biomarkers to stratify prognosis in patients with muscle-invasive bladder cancer (MIBC) undergoing radical cystectomy (RC) remain limited. This study investigated whether the expression of the recently emerging proteins Nectin4 and interferon regulatory factor 6 (IRF6) is associated with pathological stage and oncological survival outcomes in patients undergoing RC for MIBC. Materials and Methods: Two tissue microarrays comprising of 163 patients treated with RC for MIBC were analyzed at the University Hospital of Zürich. Immunohistochemistry was performed for Nectin4 and IRF6, staining intensity was quantified using H-scores. Associations with pathological stage were assessed using logistic regression. Progression-free survival (PFS) and cancer-specific survival (CSS) were evaluated using Cox regression and Kaplan-Meier analysis. Results: Higher Nectin4 and cytoplasmic IRF6 expression were significantly associated with lower pathological T-stage and AJCC stage (p

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →